Treatment of Migraines
For acute migraine treatment, combination therapy of a triptan and an NSAID or acetaminophen is recommended for nonpregnant adults with inadequate response to NSAID or acetaminophen monotherapy, as this provides superior relief compared to monotherapy. 1, 2
First-Line Treatment Algorithm
Mild to Moderate Migraine Attacks
NSAIDs or Acetaminophen
- Ibuprofen 400-600mg
- Naproxen sodium 500-550mg
- Aspirin 800-1000mg
- Acetaminophen (appropriate dosage) 2
If inadequate response:
- Consider increasing dosage (without exceeding maximum daily dose)
- Add a triptan (see combination therapy below) 1
Moderate to Severe Migraine Attacks
Triptan monotherapy (effective but less beneficial than combination therapy)
Preferred: Combination therapy
Second-Line Options
- CGRP Antagonists (Gepants) such as rimegepant, ubrogepant, or zavegepant
- Ditans (lasmiditan)
- Antiemetics (for associated nausea/vomiting) 2
Evidence Quality and Effectiveness
The American College of Physicians' 2025 clinical guideline provides strong evidence that combination therapy of a triptan with an NSAID or acetaminophen has greater net benefit than triptan monotherapy 1. Clinical trials demonstrate that sumatriptan is effective in 50-67% of patients with oral administration and 70-80% with subcutaneous administration 3, 4.
Triptans work rapidly, with headache relief often beginning within 1-2 hours of administration. FDA data shows that sumatriptan provides headache response (reduction from moderate/severe to mild/no pain) in 50-62% of patients at 2 hours and 65-79% at 4 hours, compared to only 17-27% with placebo at 2 hours 3.
Important Considerations and Caveats
Timing of Administration
- Begin treatment as early as possible after headache onset for best results 2
- Medications are most effective when taken during the mild pain phase rather than waiting until pain is severe
Medication Overuse Prevention
Limit acute medications to prevent medication overuse headache:
- Triptans: No more than 9 days per month
- NSAIDs: No more than 15 days per month
- OTC medications: No more than 14 days per month 2
Contraindications
- Triptans are contraindicated in patients with ischemic heart disease, angina, previous myocardial infarction, and uncontrolled hypertension 4
- For patients with vascular contraindications, gepants and ditans may be appropriate alternatives as they don't have vascular contraindications 5
Recurrence Management
Approximately 40% of patients who initially respond to sumatriptan may experience headache recurrence within 24 hours, but most respond well to a second dose 4
Preventive Treatment
For patients with frequent migraines (≥2 attacks per month with disability lasting ≥3 days), consider preventive therapy:
First-line preventive options:
For chronic migraine prevention:
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 2
Non-Pharmacological Approaches
- Regular exercise (aerobic, strength training, yoga)
- Sleep hygiene education
- Adequate hydration
- Identification and avoidance of triggers
- Relaxation techniques or mindfulness
- Cognitive Behavioral Therapy 2
These non-pharmacological approaches should complement, not replace, appropriate pharmacological treatment for acute attacks.